Point-of-care testing : place of France in the world National survey in healthcare establisments in 2019
The point-of-care tests (POCT) are subject to accreditation. A national inventory survey provides a synthesis of knowledge. The survey distributed 31 questions in 2019. 147 responses were received (75% biologists, 49% CHU, 42% CHG). Only 20.41% are accredited ISO22870, the majority for <50% of the medical departments; 70% say they are going there at the end of 2019 or in 2020. The maps are unknown for 32% (EBMD) and 82% (TROD). Visibility is poor with: medical establishment committee (40%), IT department (31%). Connection is necessary for 87-95% depending on the criterion (QC, authorizations, etc.) and 66% of answers highlight that less than 50% of connexion is effective. The major advantage is the delay of the result (62.5%), then the relationship with the health teams (33.3%). The disadvantages: difficulty of the quality approach (45%), cost of tests (34.3%). Human resource requirements are identified for technicians (82%) and biologists (76%). The multiplicity of sites, devices and operators means that it is difficult to set up and maintain. Biology outside the laboratories, under biological responsibility, must meet a rigorous imperative quality approach.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:78 |
|---|---|
| Enthalten in: |
Annales de biologie clinique - 78(2020), 4 vom: 01. Aug., Seite 363-382 |
| Sprache: |
Französisch |
|---|
| Weiterer Titel: |
Examens de biologie médicale délocalisée : place de la France dans le monde Enquête nationale en 2019 dans les établissements de santé |
|---|
| Beteiligte Personen: |
Beauvieux, Marie-Christine [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 12.08.2020 Date Revised 28.12.2020 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1684/abc.2020.1572 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM313285993 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM313285993 | ||
| 003 | DE-627 | ||
| 005 | 20231225150241.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||fre c | ||
| 024 | 7 | |a 10.1684/abc.2020.1572 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1044.xml |
| 035 | |a (DE-627)NLM313285993 | ||
| 035 | |a (NLM)32753365 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a fre | ||
| 100 | 1 | |a Beauvieux, Marie-Christine |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Point-of-care testing |b place of France in the world National survey in healthcare establisments in 2019 |
| 246 | 3 | 3 | |a Examens de biologie médicale délocalisée : place de la France dans le monde Enquête nationale en 2019 dans les établissements de santé |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 12.08.2020 | ||
| 500 | |a Date Revised 28.12.2020 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a The point-of-care tests (POCT) are subject to accreditation. A national inventory survey provides a synthesis of knowledge. The survey distributed 31 questions in 2019. 147 responses were received (75% biologists, 49% CHU, 42% CHG). Only 20.41% are accredited ISO22870, the majority for <50% of the medical departments; 70% say they are going there at the end of 2019 or in 2020. The maps are unknown for 32% (EBMD) and 82% (TROD). Visibility is poor with: medical establishment committee (40%), IT department (31%). Connection is necessary for 87-95% depending on the criterion (QC, authorizations, etc.) and 66% of answers highlight that less than 50% of connexion is effective. The major advantage is the delay of the result (62.5%), then the relationship with the health teams (33.3%). The disadvantages: difficulty of the quality approach (45%), cost of tests (34.3%). Human resource requirements are identified for technicians (82%) and biologists (76%). The multiplicity of sites, devices and operators means that it is difficult to set up and maintain. Biology outside the laboratories, under biological responsibility, must meet a rigorous imperative quality approach | ||
| 650 | 4 | |a Historical Article | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a ARS | |
| 650 | 4 | |a AS | |
| 650 | 4 | |a Agence régionale de santé | |
| 650 | 4 | |a CLIA | |
| 650 | 4 | |a CME | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a CQ | |
| 650 | 4 | |a Clinical laboratory improvement amendements | |
| 650 | 4 | |a Cofrac | |
| 650 | 4 | |a Comité français d’accréditation | |
| 650 | 4 | |a Comité médical d’établissement | |
| 650 | 4 | |a DIV | |
| 650 | 4 | |a DM | |
| 650 | 4 | |a EBMD | |
| 650 | 4 | |a GHT | |
| 650 | 4 | |a Groupement hospitalier de territoire | |
| 650 | 4 | |a IDE | |
| 650 | 4 | |a ISO 22 870 | |
| 650 | 4 | |a PBP | |
| 650 | 4 | |a PCR | |
| 650 | 4 | |a POCT | |
| 650 | 4 | |a RAQ | |
| 650 | 4 | |a SF | |
| 650 | 4 | |a TDR | |
| 650 | 4 | |a TROD | |
| 650 | 4 | |a accreditation | |
| 650 | 4 | |a aide-soignant | |
| 650 | 4 | |a contrôle de qualité | |
| 650 | 4 | |a diagnostic in vitro | |
| 650 | 4 | |a dispositifs médicaux | |
| 650 | 4 | |a examens de biologie médicale délocalisée | |
| 650 | 4 | |a infirmier diplômé d’Etat | |
| 650 | 4 | |a polymerase chain reaction | |
| 650 | 4 | |a pôle de biologie et pathologie | |
| 650 | 4 | |a responsable assurance qualité | |
| 650 | 4 | |a sage-femme | |
| 650 | 4 | |a survey in France | |
| 650 | 4 | |a test de diagnostic rapide | |
| 650 | 4 | |a test rapide d’orientation diagnostique | |
| 700 | 1 | |a Bost, Erika |e verfasserin |4 aut | |
| 700 | 1 | |a Castaing-Mouhica, Gladys |e verfasserin |4 aut | |
| 700 | 1 | |a Terral, Catherine |e verfasserin |4 aut | |
| 700 | 1 | |a Berthon, Nathalie |e verfasserin |4 aut | |
| 700 | 1 | |a Martinel, Isabelle |e verfasserin |4 aut | |
| 700 | 1 | |a Chauzit, Emmanuelle |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annales de biologie clinique |d 1945 |g 78(2020), 4 vom: 01. Aug., Seite 363-382 |w (DE-627)NLM000026344 |x 1950-6112 |7 nnns |
| 773 | 1 | 8 | |g volume:78 |g year:2020 |g number:4 |g day:01 |g month:08 |g pages:363-382 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1684/abc.2020.1572 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 78 |j 2020 |e 4 |b 01 |c 08 |h 363-382 | ||